Evidence map›Paper›PMID 26604905›Full record

ArticleNeural regeneration research2015

The role of Rho/Rho-kinase pathway and the neuroprotective effects of fasudil in chronic cerebral ischemia.

Ya-Yun Yan, Xiao-Ming Wang, Yan Jiang, Han Chen, Jin-Ting He, Jing Mang, Yan-Kun Shao, Zhong-Xin Xu

Open access · goldAbstract read
In one paragraph

Article in Neural regeneration research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Flavonoids fromZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Neuroprotective effects ofNeural regeneration research · 2017
    Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ya-Yun YanDepartment of Neurology, China-Japan Union Hospital, Jilin University, Changchun, Jilin Province, China.
Xiao-Ming WangDepartment of Neurology, China-Japan Union Hospital, Jilin University, Changchun, Jilin Province, China.
Yan JiangDepartment of Neurology, China-Japan Union Hospital, Jilin University, Changchun, Jilin Province, China.
Han ChenDepartment of Neurology, China-Japan Union Hospital, Jilin University, Changchun, Jilin Province, China.
Jin-Ting HeDepartment of Neurology, China-Japan Union Hospital, Jilin University, Changchun, Jilin Province, China.
Jing MangDepartment of Neurology, China-Japan Union Hospital, Jilin University, Changchun, Jilin Province, China.
Yan-Kun ShaoDepartment of Neurology, China-Japan Union Hospital, Jilin University, Changchun, Jilin Province, China.ORCID 0000-0002-1267-3208
Zhong-Xin XuDepartment of Neurology, China-Japan Union Hospital, Jilin University, Changchun, Jilin Province, China.ORCID 0000-0001-7066-7159
Union Hospital · CNJilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Rho/Rho-kinase signaling pathway plays an important role in cerebral ischemia/reperfusion injury. However, very few studies have examined in detail the changes in the Rho/Rho-kinase signaling pathway in chronic cerebral ischemia. In this study, rat models of chronic cerebral ischemia were established by permanent bilateral common carotid artery occlusion and intragastrically administered 9 mg/kg fasudil, a powerful ROCK inhibitor, for 9 weeks. Morris water maze results showed that cognitive impairment progressively worsened as the cerebral ischemia proceeded. Immunohistochemistry, semi-quantitative RT-PCR and western blot analysis showed that the expression levels of Rho-kinase, its substrate myosin-binding subunit, and its related protein alpha smooth muscle actin, significantly increased after chronic cerebral ischemia. TUNEL staining showed that chronic cerebral ischemia could lead to an increase in neuronal apoptosis, as well as the expression level of caspase-3 in the frontal cortex of rats subjected to chronic cerebral ischemia. Fasudil treatment alleviated the cognitive impairment in rats with chronic cerebral ischemia, and decreased the expression level of Rho-kinase, myosin-binding subunit and alpha smooth muscle actin. Furthermore, fasudil could regulate cerebral injury by reducing cell apoptosis and decreasing caspase-3 expression in the frontal cortex. These findings demonstrate that fasudil can protect against cognitive impairment induced by chronic cerebral ischemia via the Rho/Rho-kinase signaling pathway and anti-apoptosis mechanism.

Indexed as

alpha smooth muscle actinapoptosiscaspase-3chronic cerebral ischemiacognitive impairmentfasudilmyosin-binding subunitnerve regenerationneural regenerationRho-kinase

Identifiers

PMID26604905
PMCPMC4625510
OpenAlexW2252477353

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.